NYSE:DXCDXC Technology Stock Price, Forecast & News

DXC Technology's stock was trading at $16.43 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, DXC stock has decreased by 5.7% and is now trading at $15.50. View which stocks have been most impacted by Coronavirus.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DXC Technology in the last year. There are currently 1 sell rating, 7 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for DXC Technology.

DXC Technology is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for DXC Technology.

DXC Technology Co (NYSE:DXC) released its earnings results on Thursday, May, 28th. The company reported $1.20 EPS for the quarter, topping the Zacks' consensus estimate of $0.97 by $0.23. The firm earned $4.82 billion during the quarter, compared to analysts' expectations of $4.86 billion. DXC Technology had a negative net margin of 27.42% and a positive return on equity of 16.91%. The business's revenue for the quarter was down 8.8% compared to the same quarter last year. During the same period in the previous year, the business posted $2.19 EPS. View DXC Technology's earnings history.

DXC Technology announced a quarterly dividend on Tuesday, March 10th. Investors of record on Wednesday, March 25th will be given a dividend of $0.21 per share on Tuesday, April 14th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 5.42%. The ex-dividend date is Tuesday, March 24th. View DXC Technology's dividend history.

14 equities research analysts have issued twelve-month price targets for DXC Technology's stock. Their forecasts range from $16.00 to $82.00. On average, they anticipate DXC Technology's stock price to reach $36.00 in the next twelve months. This suggests a possible upside of 132.3% from the stock's current price. View analysts' price targets for DXC Technology.

Press coverage about DXC stock has been trending very negative this week, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. DXC Technology earned a news impact score of -3.2 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news about DXC Technology.

DXC Technology saw a decline in short interest in the month of June. As of June 15th, there was short interest totaling 8,330,000 shares, a decline of 9.9% from the May 31st total of 9,250,000 shares. Based on an average trading volume of 6,010,000 shares, the short-interest ratio is currently 1.4 days. Currently, 3.3% of the shares of the company are sold short. View DXC Technology's Current Options Chain.

Some companies that are related to DXC Technology include Bilibili (BILI), PagSeguro Digital (PAGS), StoneCo (STNE), Zendesk (ZEN), Autohome (ATHM), Zynga (ZNGA), Clarivate Analytics (CCC), Pegasystems (PEGA), Five9 (FIVN), Proofpoint (PFPT), YY (YY), Globant (GLOB), Corelogic (CLGX), LiveRamp (RAMP) and Change Healthcare (CHNG). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other DXC Technology investors own include Hewlett Packard Enterprise (HPE), HP (HPQ), NVIDIA (NVDA), Alibaba Group (BABA), AT&T (T), AbbVie (ABBV), CVS Health (CVS), Home Depot (HD), Boeing (BA) and Cisco Systems (CSCO).

DXC Technology trades on the New York Stock Exchange (NYSE) under the ticker symbol "DXC."

DXC Technology's stock is owned by many different retail and institutional investors. Top institutional shareholders include Exane Derivatives (0.05%), Envestnet Asset Management Inc. (0.02%), Arden Trust Co (0.01%), NuWave Investment Management LLC (0.00%) and Livforsakringsbolaget Skandia Omsesidigt (0.00%). Company insiders that own DXC Technology stock include Joanne Mason, John M Lawrie, Paul N Saleh and William L Deckelman, Jr. View institutional ownership trends for DXC Technology.

DXC stock was sold by a variety of institutional investors in the last quarter, including Livforsakringsbolaget Skandia Omsesidigt. View insider buying and selling activity for DXC Technology.

DXC stock was purchased by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., NuWave Investment Management LLC, Exane Derivatives, and Arden Trust Co. View insider buying and selling activity for DXC Technology.

Shares of DXC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of DXC stock can currently be purchased for approximately $15.50.

DXC Technology has a market capitalization of $3.94 billion and generates $19.58 billion in revenue each year. The company earns $-5,369,000,000.00 in net income (profit) each year or $5.58 on an earnings per share basis. DXC Technology employs 138,000 workers across the globe.

The official website for DXC Technology is www.dxc.technology.

DXC Technology's mailing address is 1775 TYSONS BOULEVARD, TYSONS VA, 22102. The company can be reached via phone at 703-245-9675 or via email at [email protected]